Dr. Robert Whitfield discusses a mouse study exposing animals to 10-HOME, a lipid molecule. The treated mice showed immune changes matching some findings in breast implant illness patients: more Th1 cells and inflammatory macrophages in breast tissue, plus fatigue-like behavior. The results suggest 10-HOME is biologically active but don't prove it causes human disease or that blocking it would help patients.
The mouse experiment can strengthen the biologic possibility because direct exposure to 10-hum reproduced selected immune findings. So after 10-hum exposure, the mice showed an increased abundance of Th1 cells in their blood. Their mammary fat tissue also showed more, showed more macrophages in and with inflammatory markers. So those findings resembled the selected immune findings seen in the human BIA group. The teno treated mice stopped more frequently and contacted with this grid more often. The authors interpreted this behavior as more fatigue-like. So the mouse experiment can strengthen the biologic possibility because direct exposure to teno reproduced selected immune findings. It gave a fatigue-like picture in this mouse model. It does not prove that Tinhome causes complete human, uh, BII-type situations. It does not establish that the experimental doses match the exact human exposure, and it does not tell us whether blocking Tinhome would improve symptoms in patients. It does tell us that the molecule is definitely biologically active, and it definitely deserves more investigation.
